Allergy Shots vs. Tablets for Asthma: Which Immunotherapy Works Best?

Living with allergic asthma means carrying a rescue inhaler, avoiding certain rooms, and hoping the pollen count stays low. But what if you could actually change how your immune system reacts to these triggers? That is exactly what Allergen Immunotherapy is a long-term treatment that gradually desensitizes the immune system to specific allergens. Unlike standard medications that just mask symptoms, this therapy targets the root cause of your allergies. The big question most patients face isn't whether it works-studies show it does-but how they want to receive it. Do you prefer the traditional clinic visits of allergy shots, or the daily convenience of sublingual tablets?

This guide breaks down the two main delivery methods: Subcutaneous Immunotherapy (SCIT), commonly known as allergy shots, and Sublingual Immunotherapy (SLIT), which uses dissolvable tablets. We will look at efficacy, safety, cost, and lifestyle impact so you can decide which path fits your life best.

How Allergen Immunotherapy Actually Works

To understand why one method might suit you better than another, you first need to know what is happening inside your body. Allergic asthma is an IgE-mediated condition. This means your immune system mistakenly identifies harmless substances-like house dust mites or grass pollen-as dangerous invaders. It produces antibodies called IgE that trigger inflammation in your airways.

Immunotherapy works by introducing tiny, controlled amounts of the allergen into your body over time. Think of it like training wheels for your immune system. At first, the dose is very small. As your body gets used to it, the dose increases until it reaches a maintenance level. Over months or years, your immune system stops overreacting. You produce fewer inflammatory cells and more regulatory antibodies, specifically IgG4, which block the allergic reaction before it starts.

The goal is not just symptom relief during treatment, but lasting tolerance after you stop. Research indicates that benefits can persist for years after completing a typical 3-to-5-year course. However, this only works if the allergen is correctly identified. If your asthma is triggered by non-allergic factors like exercise or cold air, immunotherapy won't help. Precise testing via skin prick tests or specific IgE blood tests is mandatory before starting.

Allergy Shots (SCIT): The Traditional Gold Standard

Subcutaneous Immunotherapy (SCIT) involves injecting allergen extracts under the skin. This method has been around since 1911, making it the oldest form of immunotherapy. Because it delivers the allergen directly into the tissue, it tends to be highly potent.

Here is how the process typically unfolds:

• Build-up Phase: You visit the clinic weekly for 3 to 6 months. Each week, the dose increases slightly.
• Maintenance Phase: Once you reach the target dose, visits drop to once every 4 to 8 weeks. This phase lasts for 3 to 5 years.
• Total Visits: Expect roughly 50 to 70 clinic visits over the entire treatment period.

The biggest advantage of SCIT is its track record. For decades, it has been the go-to treatment for moderate-to-severe allergic asthma. Studies consistently show it reduces asthma symptoms and medication use significantly. Some older research even suggested it might be slightly more effective than tablets for severe cases. Additionally, because you are in a medical facility, any adverse reactions are managed immediately by professionals.

However, the downside is clear: it demands a lot of your time. Missing appointments disrupts the dosing schedule, which can reduce effectiveness. There is also a higher risk of systemic reactions compared to tablets, though serious events like anaphylaxis are rare when protocols are followed strictly.

SLIT Tablets: Convenience Meets Modern Science

Sublingual Immunotherapy (SLIT) uses standardized tablets placed under the tongue. These tablets dissolve and absorb through the mucous membrane in your mouth. Unlike custom-made shot extracts, SLIT tablets are manufactured pharmaceutical products with strict quality controls.

Common approved tablets include ACARIZAX for house dust mites and GRAZAX for grass pollen. These are standardized to specific units (e.g., 6 SQ-HDM for dust mite) ensuring consistency across batches.

The administration routine looks like this:

• First Dose: Must be taken in a clinic under supervision due to the risk of initial systemic reactions.
• Daily Routine: After the first dose, you take one tablet daily at home, usually in the morning on an empty stomach.
• Technique: Place the tablet under the tongue and let it dissolve completely (about 2 minutes) before swallowing.

Recent real-world studies have shifted the perspective on SLIT. A large propensity-matched study involving over 14,000 patients found that those using SLIT saw significant reductions in both rhinitis and asthma medication prescriptions over nine years. Specifically, for house dust mite-driven asthma, patients achieved a 42% reduction in daily inhaled corticosteroid doses compared to placebo. This is a substantial clinical benefit.

The primary draw here is freedom. No weekly clinic visits. You manage your treatment while working, traveling, or living your normal life. Adherence rates for SLIT often hit 75-80%, higher than SCIT's 60-65%, largely because fitting a pill into your day is easier than scheduling fifty doctor appointments.

Head-to-Head Comparison: Efficacy and Safety

Choosing between shots and tablets often comes down to balancing efficacy against convenience and safety. Here is a detailed breakdown of how they stack up based on current clinical data.

Efficacy-wise, both methods work well for mild-to-moderate allergic asthma. Older studies sometimes favored shots for severe asthma, but newer data suggests tablets are equally effective for perennial triggers like house dust mites. The key difference lies in safety. SCIT carries a higher risk of systemic reactions, including anaphylaxis, which is why observation periods are mandatory. SLIT reactions are usually localized to the mouth (itching, swelling) and rarely progress to severe systemic issues.

Another critical factor is allergen specificity. SCIT can be customized to treat multiple allergens simultaneously (e.g., cat dander, ragweed, and dust mites). SLIT tablets are currently approved for only a few major allergens. If you are allergic to something obscure or a complex mix not covered by commercial tablets, shots may be your only option.

Who Should Avoid Immunotherapy?

Not everyone is a candidate for either method. Before considering AIT, your doctor will evaluate several contraindications. You should generally avoid immunotherapy if:

• You have severe uncontrolled asthma: If you are on GINA Step 4 or 5 treatments (high-dose steroids, biologics), adding immunotherapy can be risky. Your asthma needs to be stable first.
• You have cardiovascular disease: Conditions like angina or heart failure can complicate the management of potential allergic reactions.
• You are pregnant: While continuing existing therapy might be safe, starting new immunotherapy during pregnancy is usually discouraged due to unknown risks.
• You cannot adhere to the schedule: Whether it's missing weekly shots or forgetting daily pills, inconsistent dosing renders the treatment ineffective.

Additionally, if your asthma is not primarily driven by IgE-mediated allergies (e.g., it's caused by viral infections or pollution), immunotherapy will offer little benefit. Accurate diagnostic testing is the gatekeeper here.

Long-Term Benefits Beyond Symptom Relief

One of the most compelling arguments for immunotherapy is its disease-modifying effect. Most asthma drugs are palliative-they work only while you take them. Immunotherapy changes the underlying biology.

Studies show that patients who complete a full course of AIT experience fewer asthma exacerbations even years after stopping treatment. A retrospective study of nearly 2,700 patients found a 20% decrease in lower respiratory tract infections requiring antibiotics among perennial allergic asthmatics after discontinuing AIT. This suggests a broader improvement in respiratory health.

There is also evidence that early intervention can prevent disease progression. Children treated for allergic rhinitis with immunotherapy had a significantly lower risk of developing asthma later in life. Nine out of ten studies reviewed by experts confirmed this protective effect. For parents, this preventive aspect might outweigh the inconvenience of daily tablets or weekly shots.

Practical Considerations: Cost and Accessibility

Money and logistics play a huge role in choosing a treatment. In many regions, including parts of Europe, AIT is widely reimbursed. In the United States, coverage varies. SCIT is often covered by insurance, but the copays for frequent visits add up. SLIT tablets are expensive pharmaceutical products, and prior authorization from insurers can be a hurdle.

Consider your lifestyle. If you travel frequently or work irregular hours, the rigidity of weekly shot appointments might be stressful. SLIT offers flexibility, but requires discipline. Forgetting a dose occasionally is less impactful than missing a whole month, but consistency matters for optimal results.

Geography also matters. Access to specialized allergy clinics offering SCIT is widespread. However, finding a provider familiar with SLIT protocols and willing to supervise the first dose can be harder in some areas. Always check with local specialists about their experience with both modalities.

Making Your Decision

So, which is right for you? If you have mild-to-moderate asthma triggered by house dust mites or grass pollen, and you value convenience and safety, SLIT tablets are likely the better choice. They offer proven efficacy with minimal disruption to your daily life.

If you have complex allergies not covered by commercial tablets, or if you struggle with daily adherence, allergy shots provide a structured, supervised environment with a long history of success. They require more time commitment but offer broader allergen coverage.

Ultimately, the best immunotherapy is the one you stick with. Both options offer a chance to breathe easier, reduce medication reliance, and potentially alter the course of your allergic disease. Discuss your specific triggers, lifestyle, and health history with an allergist to tailor the plan to your needs.